Nat Simons Charles River Laboratories International, Inc. Transaction History
Meritage Group LP
- $3.77 Billion
- Q3 2024
A detailed history of Nat Simons (Meritage Group LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meritage Group LP holds 1,185,167 shares of CRL stock, worth $223 Million. This represents 6.2% of its overall portfolio holdings.
Number of Shares
1,185,167
Previous 1,182,657
0.21%
Holding current value
$223 Million
Previous $244 Million
4.44%
% of portfolio
6.2%
Previous 6.95%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$703 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$400 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...